One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.

Goran PetrovskiFawziya Al KhalafJudith CampbellFareeda UmerDouha AlmajalyManar HamdanKhalid Hussain

Published in: Acta diabetologica (2020)

HCL system (MiniMed 670G) in children and adolescents previously treated with MDI significantly improves glycemic outcomes (HbA1c and Time in Ranges) immediately during the first month. This improved glycemic control was maintained over the 1 year following Auto Mode initiation.

Keyphrases

glycemic control
type diabetes
blood glucose
weight loss
physical activity
insulin resistance
newly diagnosed
metabolic syndrome
skeletal muscle